| Absorption |
| Blood-Brain Barrier | BBB+ | 0.5829 |
| Human Intestinal Absorption | HIA+ | 0.9959 |
| Caco-2 Permeability | Caco2+ | 0.9165 |
| P-glycoprotein Substrate | Non-substrate | 0.7115 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9792 |
| Non-inhibitor | 0.9866 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8890 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8395 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7577 |
| CYP450 2D6 Substrate | Non-substrate | 0.8555 |
| CYP450 3A4 Substrate | Non-substrate | 0.7090 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7361 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8619 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9791 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9055 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8508 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7961 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8554 |
| Non-inhibitor | 0.9547 |
| AMES Toxicity | Non AMES toxic | 0.9633 |
| Carcinogens | Non-carcinogens | 0.7310 |
| Fish Toxicity | Low FHMT | 0.5435 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8518 |
| Honey Bee Toxicity | High HBT | 0.7834 |
| Biodegradation | Ready biodegradable | 0.6070 |
| Acute Oral Toxicity | II | 0.5252 |
| Carcinogenicity (Three-class) | Non-required | 0.5775 |